January 5, 2023 12:45 PM ESTUpdated March 23, 12:44 PM
Manufacturing

Man­u­fac­tur­ing roundup: Lotte nabs BMS fa­cil­i­ty in New York; Al­ca­mi ac­qui­si­tion com­plete

Tyler Patchen

News Reporter

Bris­tol My­ers Squibb is hand­ing over the keys to its man­u­fac­tur­ing site in Syra­cuse, NY, to South Ko­re­an com­pa­ny Lotte Bi­o­log­ics.

BMS

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times